Carglumic acid is used in the management of rare, life-threatening inborn metabolic disorders affecting the urea cycle. Dipharma S.A., a Swiss pharmaceutical company specialized in developing ...
NEW HAVEN, Conn., Jan. 9, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company") announced positive results today from its bioequivalence study ...
Adding to its store of technology weapons, Catalent Pharma can now offer fast-dissolve tablet technology to clients. It obtained the development rights to Lyopan from Pantec. The lyophilized tablets ...
SOMERSET, NJ, February 15, 2011 - Catalent Pharma Solutions, the world's leading provider of advanced oral drug delivery technologies and solutions, announced that it has entered into a license ...
NASHVILLE, Tenn.--(BUSINESS WIRE)--Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced it recently entered into an ...
The FDA has approved the world's first 3D-printed drug Spritam, a fast-dissolving tablet that can be printed up to 1,000mg to make it easier for epilepsy patients to swallow Aprecia Pharmaceuticals ...
Aprecia's Spritam tablets, quickly dissolvable in liquid--Courtesy of Aprecia The FDA on Monday approved Aprecia Pharmaceuticals' Spritam, which is the first 3-D printed product designed for use in ...
The authors formulated and developed taste-masked RDFs of cetirizine hydrochloride for patients who experience difficulty in swallowing the tablet dosage form of the drug. Rapidly dissolving dosage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results